Copyright Reports & Markets. All rights reserved.

Global 4D Proton Therapy System Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global 4D Proton Therapy System Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Fixed
    • 1.3.3 Mobile
  • 1.4 Market Analysis by Motion Management Method
    • 1.4.1 Overview: Global 4D Proton Therapy System Consumption Value by Motion Management Method: 2021 Versus 2025 Versus 2032
    • 1.4.2 Internal Target Volume (ITV)
    • 1.4.3 Respiratory Gating
    • 1.4.4 Others
  • 1.5 Market Analysis by Motion Signal Source
    • 1.5.1 Overview: Global 4D Proton Therapy System Consumption Value by Motion Signal Source: 2021 Versus 2025 Versus 2032
    • 1.5.2 External Marker Monitoring
    • 1.5.3 Surface Imaging
    • 1.5.4 Implanted Marker
    • 1.5.5 Electromagnetic Tracking
  • 1.6 Market Analysis by Image-guided Technology
    • 1.6.1 Overview: Global 4D Proton Therapy System Consumption Value by Image-guided Technology: 2021 Versus 2025 Versus 2032
    • 1.6.2 4D CT Simulation/Localization
    • 1.6.3 4D Cone-beam CT
    • 1.6.4 Orthogonal X-ray Tracking
    • 1.6.5 Real-time MRI-guided
    • 1.6.6 Others
  • 1.7 Market Analysis by Application
    • 1.7.1 Overview: Global 4D Proton Therapy System Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.7.2 Thoracic Tumor
    • 1.7.3 Abdominal Tumor
    • 1.7.4 Pelvic Tumor
    • 1.7.5 Others
  • 1.8 Global 4D Proton Therapy System Market Size & Forecast
    • 1.8.1 Global 4D Proton Therapy System Consumption Value (2021 & 2025 & 2032)
    • 1.8.2 Global 4D Proton Therapy System Sales Quantity (2021-2032)
    • 1.8.3 Global 4D Proton Therapy System Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 MHI
    • 2.1.1 MHI Details
    • 2.1.2 MHI Major Business
    • 2.1.3 MHI 4D Proton Therapy System Product and Services
    • 2.1.4 MHI 4D Proton Therapy System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 MHI Recent Developments/Updates
  • 2.2 GE HealthCare
    • 2.2.1 GE HealthCare Details
    • 2.2.2 GE HealthCare Major Business
    • 2.2.3 GE HealthCare 4D Proton Therapy System Product and Services
    • 2.2.4 GE HealthCare 4D Proton Therapy System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 GE HealthCare Recent Developments/Updates
  • 2.3 Elekta
    • 2.3.1 Elekta Details
    • 2.3.2 Elekta Major Business
    • 2.3.3 Elekta 4D Proton Therapy System Product and Services
    • 2.3.4 Elekta 4D Proton Therapy System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Elekta Recent Developments/Updates
  • 2.4 Varian
    • 2.4.1 Varian Details
    • 2.4.2 Varian Major Business
    • 2.4.3 Varian 4D Proton Therapy System Product and Services
    • 2.4.4 Varian 4D Proton Therapy System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Varian Recent Developments/Updates
  • 2.5 C-RAD
    • 2.5.1 C-RAD Details
    • 2.5.2 C-RAD Major Business
    • 2.5.3 C-RAD 4D Proton Therapy System Product and Services
    • 2.5.4 C-RAD 4D Proton Therapy System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 C-RAD Recent Developments/Updates
  • 2.6 Siemens
    • 2.6.1 Siemens Details
    • 2.6.2 Siemens Major Business
    • 2.6.3 Siemens 4D Proton Therapy System Product and Services
    • 2.6.4 Siemens 4D Proton Therapy System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Siemens Recent Developments/Updates
  • 2.7 Philips Healthcare
    • 2.7.1 Philips Healthcare Details
    • 2.7.2 Philips Healthcare Major Business
    • 2.7.3 Philips Healthcare 4D Proton Therapy System Product and Services
    • 2.7.4 Philips Healthcare 4D Proton Therapy System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Philips Healthcare Recent Developments/Updates

3 Competitive Environment: 4D Proton Therapy System by Manufacturer

  • 3.1 Global 4D Proton Therapy System Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global 4D Proton Therapy System Revenue by Manufacturer (2021-2026)
  • 3.3 Global 4D Proton Therapy System Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of 4D Proton Therapy System by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 4D Proton Therapy System Manufacturer Market Share in 2025
    • 3.4.3 Top 6 4D Proton Therapy System Manufacturer Market Share in 2025
  • 3.5 4D Proton Therapy System Market: Overall Company Footprint Analysis
    • 3.5.1 4D Proton Therapy System Market: Region Footprint
    • 3.5.2 4D Proton Therapy System Market: Company Product Type Footprint
    • 3.5.3 4D Proton Therapy System Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global 4D Proton Therapy System Market Size by Region
    • 4.1.1 Global 4D Proton Therapy System Sales Quantity by Region (2021-2032)
    • 4.1.2 Global 4D Proton Therapy System Consumption Value by Region (2021-2032)
    • 4.1.3 Global 4D Proton Therapy System Average Price by Region (2021-2032)
  • 4.2 North America 4D Proton Therapy System Consumption Value (2021-2032)
  • 4.3 Europe 4D Proton Therapy System Consumption Value (2021-2032)
  • 4.4 Asia-Pacific 4D Proton Therapy System Consumption Value (2021-2032)
  • 4.5 South America 4D Proton Therapy System Consumption Value (2021-2032)
  • 4.6 Middle East & Africa 4D Proton Therapy System Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global 4D Proton Therapy System Sales Quantity by Type (2021-2032)
  • 5.2 Global 4D Proton Therapy System Consumption Value by Type (2021-2032)
  • 5.3 Global 4D Proton Therapy System Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global 4D Proton Therapy System Sales Quantity by Application (2021-2032)
  • 6.2 Global 4D Proton Therapy System Consumption Value by Application (2021-2032)
  • 6.3 Global 4D Proton Therapy System Average Price by Application (2021-2032)

7 North America

  • 7.1 North America 4D Proton Therapy System Sales Quantity by Type (2021-2032)
  • 7.2 North America 4D Proton Therapy System Sales Quantity by Application (2021-2032)
  • 7.3 North America 4D Proton Therapy System Market Size by Country
    • 7.3.1 North America 4D Proton Therapy System Sales Quantity by Country (2021-2032)
    • 7.3.2 North America 4D Proton Therapy System Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe 4D Proton Therapy System Sales Quantity by Type (2021-2032)
  • 8.2 Europe 4D Proton Therapy System Sales Quantity by Application (2021-2032)
  • 8.3 Europe 4D Proton Therapy System Market Size by Country
    • 8.3.1 Europe 4D Proton Therapy System Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe 4D Proton Therapy System Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific 4D Proton Therapy System Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific 4D Proton Therapy System Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific 4D Proton Therapy System Market Size by Region
    • 9.3.1 Asia-Pacific 4D Proton Therapy System Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific 4D Proton Therapy System Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America 4D Proton Therapy System Sales Quantity by Type (2021-2032)
  • 10.2 South America 4D Proton Therapy System Sales Quantity by Application (2021-2032)
  • 10.3 South America 4D Proton Therapy System Market Size by Country
    • 10.3.1 South America 4D Proton Therapy System Sales Quantity by Country (2021-2032)
    • 10.3.2 South America 4D Proton Therapy System Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa 4D Proton Therapy System Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa 4D Proton Therapy System Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa 4D Proton Therapy System Market Size by Country
    • 11.3.1 Middle East & Africa 4D Proton Therapy System Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa 4D Proton Therapy System Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 4D Proton Therapy System Market Drivers
  • 12.2 4D Proton Therapy System Market Restraints
  • 12.3 4D Proton Therapy System Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of 4D Proton Therapy System and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of 4D Proton Therapy System
  • 13.3 4D Proton Therapy System Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 4D Proton Therapy System Typical Distributors
  • 14.3 4D Proton Therapy System Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global 4D Proton Therapy System market size was valued at US$ 317 million in 2025 and is forecast to a readjusted size of US$ 558 million by 2032 with a CAGR of 7.7% during review period.
    In 2025, the global production volume of 4D proton therapy systems is approximately 875 units, with an average global market price of around $352,000 per unit. The total global production capacity for these systems is estimated to reach approximately 1,600 units in 2025. The average gross profit margin for the industry is approximately 49%. A 4D proton therapy system is an integrated treatment system that builds upon standard proton radiotherapy by incorporating positional changes of tumors and normal organs—caused by respiration, heartbeat, or other physiological movements—into the entire process of simulation, treatment planning, image guidance, dose calculation, and beam delivery. The term "4D" refers to three spatial dimensions plus the time dimension; it does not denote a new type of proton. Such systems typically comprise a cyclotron or synchrotron, energy selection and beam transport devices, a gantry, a pencil-beam scanning system, 4D CT or 4D cone-beam CT (CBCT), a treatment planning system, respiratory monitoring equipment, patient positioning systems, and software for gating, breath-holding, rescanning, or real-time tracking. Proton beams are characterized by a finite range and the Bragg peak, allowing for high-dose concentration at the target depth while minimizing the dose to distal normal tissues; however, their dose distribution is sensitive to variations in tissue density and motion, making 4D motion management particularly crucial for treating tumors in the lung, liver, pancreas, and the thoracic or abdominal regions. The IAEA identifies respiratory gating, 4D planning, verification imaging, and intra-treatment target visualization as key components of advanced radiotherapy capabilities.
    The upstream supply chain primarily encompasses large-scale core equipment—such as cyclotrons, synchrotrons, superconducting magnets, RF systems, ion sources, vacuum equipment, beam transport magnets, energy selection systems, and gantries—as well as components like pencil-beam scanning magnets, dose-monitoring ionization chambers, position detectors, and rapid beam switches. 4D functionality also relies on CT detectors, flat-panel detectors, CBCT systems, respiratory pressure belts, optical surface monitoring equipment, infrared markers, implanted fiducials, and patient immobilization devices. Upstream software and algorithms include those for 4D image reconstruction, deformable image registration, proton range calculation, robust optimization, motion prediction, and dose accumulation. Because proton range is affected by changes in patient tissue density and anatomical positioning, upstream components must ensure precision in beam energy, position, and dosage while maintaining high temporal responsiveness to accurately synchronize respiratory signals, imaging, and proton beam switching. Proton therapy centers also typically require comprehensive dosimetry and quality assurance equipment to commission and periodically verify the accelerator, imaging, and beam delivery systems. The midstream of the industry chain comprises manufacturers of proton therapy systems, medical imaging companies, treatment planning software vendors, and hospital engineering integrators; they are primarily responsible for the integrated assembly of accelerators, rotating gantries, pencil beam scanning (PBS) systems, image guidance, patient positioning, treatment planning, and motion management systems. Typical workflows involve 4D CT simulation and localization, image reconstruction across respiratory phases, tumor motion assessment, robust treatment planning, pre-treatment image verification, and intra-treatment techniques such as respiratory gating, breath-holding, and volumetric (layer or voxel) rescanning. Compared to photon therapy, scanning proton beams can give rise to an "interplay effect"—where the beam scanning pattern interacts with tumor motion—potentially leading to localized dose overdoses or underdoses; consequently, midstream vendors must mitigate these risks through faster scanning speeds, multiple rescanning, respiratory synchronization, and 4D dose calculation. 4D-CBCT is being investigated for daily internal motion monitoring during PBS proton therapy, and existing commercial proton platforms are continuously upgrading their gantry-mounted CBCT and adaptive therapy capabilities. The downstream sector primarily includes large general hospitals, specialized cancer hospitals, regional proton therapy centers, pediatric oncology centers, and research institutions. 4D proton therapy is primarily utilized for lung, liver, pancreatic, and esophageal cancers, as well as thoracic and abdominal tumors and cases involving organs adjacent to critical structures like the heart, lungs, or gastrointestinal tract; it is also suitable for pediatric and young patients requiring reduced low-dose exposure to healthy tissue. When procuring these systems, hospitals must comprehensively evaluate factors such as the number of treatment rooms, proton energy range, PBS speed, image guidance configurations, motion management capabilities, treatment planning software, quality control systems, and long-term maintenance services. These systems are not merely standalone pieces of equipment but comprehensive clinical solutions encompassing simulation, planning, treatment delivery, imaging, and quality control; compact single-room systems coexist with multi-room proton centers. Future downstream demand will drive system evolution toward real-time imaging, online adaptive proton therapy, markerless motion tracking, faster scanning, and AI-assisted planning; however, widespread adoption remains constrained by high capital investment, specialized facility construction, the need for skilled clinical teams, and rigorous quality assurance requirements. IBA’s current single-room system integrates PBS and CBCT, positioning itself for image-guided intensity-modulated proton therapy.
    Proton beams offer the advantages of a finite range and the Bragg peak, allowing for reduced radiation doses to normal tissues distal to the target; however, their dose distribution is also more susceptible to the effects of respiration, organ deformation, and tissue density variations. For tumors exhibiting significant motion—such as those in the lung, liver, pancreas, and esophagus—relying solely on static 3D planning may result in range shifts or target dose under-coverage. Consequently, clinical facilities must incorporate the temporal dimension into treatment planning and dose verification through methods such as 4D CT, breath-holding, respiratory gating, and motion-robust optimization. Clinical consensus from PTCOG also emphasizes the use of 4D CT to assess thoracic tumor motion and the implementation of motion mitigation strategies and 4D robustness evaluations as needed.
    Pencil beam scanning allows for precise control over the position, depth, and intensity of proton beam spots; however, under free-breathing conditions, an "interplay effect" between the scanning beam and tumor motion can occur, leading to localized dose hotspots or cold spots. As proton therapy centers increasingly adopt scanning beams to replace traditional passive scattering, techniques such as respiratory gating, deep-inspiration breath-hold (DIBH), layered rescanning, and volumetric rescanning are becoming standard features. Existing commercial systems already support various motion management strategies—including breath-hold, free-breathing, gating, and layered rescanning—indicating that 4D capabilities are shifting from optional add-ons to integral components of scanning proton therapy.
    Currently, most 4D proton therapy relies on pre-treatment 4D CT, motion envelopes, robust planning, and pre-treatment image verification. Future systems will enhance capabilities such as gantry-mounted CBCT, respiratory phase imaging, real-time tumor tracking, rapid beam switching, and online plan re-optimization, enabling dynamic adjustment of proton beam delivery based on the patient's daily anatomy and respiratory status. Technological competition will focus on faster energy layer switching, higher scanning speeds, low-latency gating, 4D dose accumulation, and online range verification. PTCOG has identified 4D plan optimization, motion modeling, image guidance, and real-time adaptive radiotherapy as key frontiers in scanning proton therapy.
    Report Scope
    This report is a detailed and comprehensive analysis for global 4D Proton Therapy System market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global 4D Proton Therapy System market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global 4D Proton Therapy System market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global 4D Proton Therapy System market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global 4D Proton Therapy System market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for 4D Proton Therapy System
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global 4D Proton Therapy System market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include MHI, GE HealthCare, Elekta, Varian, C-RAD, Siemens, Philips Healthcare, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    4D Proton Therapy System market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market Segmentation
    Market segment by Type
    Fixed
    Mobile
    Market segment by Motion Management Method
    Internal Target Volume (ITV)
    Respiratory Gating
    Others
    Market segment by Motion Signal Source
    External Marker Monitoring
    Surface Imaging
    Implanted Marker
    Electromagnetic Tracking
    Market segment by Image-guided Technology
    4D CT Simulation/Localization
    4D Cone-beam CT
    Orthogonal X-ray Tracking
    Real-time MRI-guided
    Others
    Market segment by Application
    Thoracic Tumor
    Abdominal Tumor
    Pelvic Tumor
    Others
    Major players covered
    MHI
    GE HealthCare
    Elekta
    Varian
    C-RAD
    Siemens
    Philips Healthcare
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    Chapter Outline
    Chapter 1, to describe 4D Proton Therapy System product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of 4D Proton Therapy System, with price, sales quantity, revenue, and global market share of 4D Proton Therapy System from 2021 to 2026.
    Chapter 3, the 4D Proton Therapy System competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the 4D Proton Therapy System breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and 4D Proton Therapy System market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of 4D Proton Therapy System.
    Chapter 14 and 15, to describe 4D Proton Therapy System sales channel, distributors, customers, research findings and conclusion.

    Buy now